Risk Factors for Urosepsis After Ureteroscopy for Stone Disease

Stone disease is on the rise and ureteroscopy is one of the most commonly used treatment options for patients. Naeem Bhojani, MD, discusses his recent systematic review with meta-analysis and identifies risk factors that can potentially lead to urosepsis. To learn more and view the full-length discussion, visit EDUCARE.

Naeem Bhojani, MD, Associate Professor of Urology, University of Montreal, Canada

Related Content

Discovery: Service Line Challenges and Its Impact on Endourology

Maximize Perioperative Efficiency in the Ureteroscopy Suite

IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural steps but may not be appropriate for every patient or case. Decisions surrounding patient care depend on the physician’s professional judgement in consideration of all available information for the individual case. Boston Scientific (BSC) does not promote or encourage the use of its devices outside their approved labeling.

All the images and videos are being provided for healthcare professional use only. This information does not constitute medical or legal advice. and Boston Scientific makes no representation regarding the medical benefits included in this information. Boston Scientific strongly recommends that you consult with your physician on all matters pertaining to your health.

This educational video was produced in cooperation with Dr. Naeem Bhojani. The video was sponsored by Boston Scientific and Boston Scientific participated in the authorship of the underlying article.

Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labelling supplied with each device. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.

All trademarks are the property of their respective owners.

© 2021 Boston Scientific Corporation. All rights reserved.